Systematic review of the cost-effectiveness of transcatheter aortic valve implantation

Ben-Dor, 2010, Correlates and causes of death in patients with severe symptomatic aortic stenosis who are not eligible to participate in a clinical trial of transcatheter aortic valve implantation, Circulation, 122, S37, 10.1161/CIRCULATIONAHA.109.926873 Smith, 2011, Transcatheter versus surgical aortic-valve replacement in high-risk patients, N Engl J Med, 364, 2187, 10.1056/NEJMoa1103510 Van Brabandt, 2012, Transcatheter aortic valve implantation (TAVI): risky and costly, BMJ, 345, e4710, 10.1136/bmj.e4710 Neyt, 2012, A cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable population, BMJ Open, 2, e001032, 10.1136/bmjopen-2012-001032 Reynolds, 2012, Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis, Circulation, 125, 1102, 10.1161/CIRCULATIONAHA.111.054072 Watt, 2012, Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement, Heart, 98, 370, 10.1136/heartjnl-2011-300444 Doble, 2013, Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective, J Thorac Cardiovasc Surg, 146, 52, 10.1016/j.jtcvs.2012.06.018 Gada, 2012, Markov model for selection of aortic valve replacement versus transcatheter aortic valve implantation (without replacement) in high-risk patients, Am J Cardiol, 109, 1326, 10.1016/j.amjcard.2011.12.030 Osnabrugge, 2012, Costs of transcatheter versus surgical aortic valve replacement in intermediate risk patients, Ann Thorac Surg, 94, 1954, 10.1016/j.athoracsur.2012.07.002 Reynolds, 2012, Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis, J Am Coll Cardiol, 60, 2683, 10.1016/j.jacc.2012.09.018 Gada, 2012, Perspective on the cost-effectiveness of transapical aortic valve implantation in high-risk patients: outcomes of a decision analytic model, Ann Cardiothorac Surg, 1, 145 Kodali, 2012, Two-year outcomes after transcatheter or surgical aortic-valve replacement, N Engl J Med, 366, 1686, 10.1056/NEJMoa1200384 Shaw, 1997, A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology: part II, J Nucl Cardiol, 4, 52, 10.1016/S1071-3581(97)90049-0 2008 World Health Organization. Cost effectiveness ratio thresholds. Available at: http://www.who.int/entity/choice/costs/CER_thresholds_regions.xls. Accessed December 1, 2012. Hlatky, 2012, Cost-effectiveness of transcatheter aortic valve replacement, Circulation, 125, 1076, 10.1161/CIRCULATIONAHA.112.091322 Cao, 2013, Systematic review and meta-analysis of transcatheter aortic valve implantation versus surgical aortic valve replacement for patients with severe aortic stenosis, Ann Cardiothorac Surg, 2, 10 International Federation of Health Plans. Comparative Price Report 2011. Available at: http://www.ifhp.com/documents/2011iFHPPriceReportGraphs_version3.pdf. Accessed December 1, 2012. Neilsen, 2012, A prospective, randomised trial of transapical transcatheter aortic valve implantation vs. surgical aortic valve replacement in operable elderly patients with aortic stenosis: the STACCATO trial, Eurointervention, 8, 383, 10.4244/EIJV8I3A58 Medtronic CoreValve. CoreValve U.S. Pivotal Trial 2011. Available at: http://www.medtronic.com/aorticstenosistrial/trial.html. Accessed November 15, 2012.